{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:23:05Z","timestamp":1784755385149,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36643-7","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:19:50Z","timestamp":1770646790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advanced oxidation protein products and ischemia-modified albumin as prognostic biomarkers of long-term mortality in community-acquired pneumonia: a prospective observational study"],"prefix":"10.1038","volume":"16","author":[{"given":"Marta","family":"Napi\u00f3rkowska-Mastalerz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wybranowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Wszelaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Pyskir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Michalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pilaczy\u0144ska-Cemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ciastek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"36643_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches, I. et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 49, 615\u2013632 (2023).","journal-title":"Intensive Care Med."},{"key":"36643_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41479-020-00074-3","volume":"12","author":"S Shoar","year":"2020","unstructured":"Shoar, S. & Musher, D. M. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia 12, 11 (2020).","journal-title":"Pneumonia"},{"key":"36643_CR3","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1186\/cc11471","volume":"16","author":"N Mongardon","year":"2012","unstructured":"Mongardon, N. et al. Epidemiology and outcome of severe Pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit. Care. 16, R155 (2012).","journal-title":"Crit. Care"},{"key":"36643_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/14760584.2023.2261785","volume":"22","author":"E Tsoumani","year":"2023","unstructured":"Tsoumani, E., Carter, J. A., Salomonsson, S., Stephens, J. M. & Bencina, G. Clinical, economic, and humanistic burden of community acquired pneumonia in europe: a systematic literature review. Expert Rev. Vaccines. 22, 876\u2013884 (2023).","journal-title":"Expert Rev. Vaccines"},{"key":"36643_CR5","doi-asserted-by":"publisher","first-page":"e0191721","DOI":"10.1371\/journal.pone.0191721","volume":"13","author":"M Ferrer","year":"2018","unstructured":"Ferrer, M. et al. Severe community-acquired pneumonia: characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS One. 13, e0191721 (2018).","journal-title":"PLoS One"},{"key":"36643_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1378\/chest.130.4.1165","volume":"130","author":"R Moussaoui","year":"2006","unstructured":"Moussaoui, R. et al. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest 130, 1165\u20131172 (2006).","journal-title":"Chest"},{"key":"36643_CR7","first-page":"e36052","volume":"15","author":"P Carlos","year":"2023","unstructured":"Carlos, P. et al. CURB-65 and Long-Term mortality of Community-Acquired pneumonia: A retrospective study on hospitalized patients. Cureus 15, e36052 (2023).","journal-title":"Cureus"},{"key":"36643_CR8","first-page":"158","volume":"49","author":"A Agita","year":"2017","unstructured":"Agita, A. & Thaha Alsagaff, M. Inflammation, Immunity, and hypertension. Acta Med. Indones. 49, 158\u2013165 (2017).","journal-title":"Acta Med. Indones"},{"key":"36643_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fendo.2020.00400","volume":"11","author":"W Xu","year":"2020","unstructured":"Xu, W., Zhao, T. & Xiao, H. The implication of oxidative stress and AMPK-Nrf2 antioxidative signaling in pneumonia pathogenesis. Front. Endocrinol. 11, 400 (2020).","journal-title":"Front. Endocrinol."},{"key":"36643_CR10","first-page":"1","volume":"10","author":"F Makram Youssef","year":"2024","unstructured":"Makram Youssef, F., Elmokadem, E. M., Eskander, A., Samy, H. & Ateyya, H. Antioxidants as adjuvant therapy in the treatment of community-acquired pneumonia. Future J. Pharm. Sci. 10, 1\u201319 (2024).","journal-title":"Future J. Pharm. Sci."},{"key":"36643_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12012-016-9377-8","volume":"17","author":"H Ou","year":"2017","unstructured":"Ou, H., Huang, Z., Mo, Z. & Xiao, J. The characteristics and roles of advanced oxidation protein products in atherosclerosis. Cardiovasc. Toxicol. 17, 1\u201312 (2017).","journal-title":"Cardiovasc. Toxicol."},{"key":"36643_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/medicina55100675","volume":"55","author":"G Conti","year":"2019","unstructured":"Conti, G. et al. Association of higher advanced oxidation protein products (AOPPs) levels in patients with diabetic and hypertensive nephropathy. Medicina 55, 675 (2019).","journal-title":"Medicina"},{"key":"36643_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/antiox13060681","volume":"13","author":"SI Anjo","year":"2024","unstructured":"Anjo, S. I. et al. Protein oxidative modifications in neurodegenerative diseases: from advances in detection and modelling to their use as disease biomarkers. Antioxidants 13, 681 (2024).","journal-title":"Antioxidants"},{"key":"36643_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/cancers16051068","volume":"16","author":"M Napi\u00f3rkowska-Mastalerz","year":"2024","unstructured":"Napi\u00f3rkowska-Mastalerz, M. et al. A preliminary evaluation of advanced oxidation protein products (AOPPs) as a potential approach to evaluating prognosis in Early-Stage breast cancer patients and its implication in tumour angiogenesis: A 7-Year Single-Centre study. Cancers (Basel). 16, 1068 (2024).","journal-title":"Cancers (Basel)"},{"key":"36643_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-021-02960-w","volume":"19","author":"C Zhou","year":"2021","unstructured":"Zhou, C. et al. Association between serum advanced oxidation protein products and mortality risk in maintenance Hemodialysis patients. J. Transl Med. 19, 1\u20138 (2021).","journal-title":"J. Transl Med."},{"key":"36643_CR16","first-page":"245","volume":"3","author":"NN Senadeera","year":"2024","unstructured":"Senadeera, N. N., Ranaweera, C. B., Perera, I. C. & Kottahachchi, D. U. Biochemical insights and clinical applications of Ischemia-Modified albumin in ischemic conditions. J. Vasc Dis. 3, 245\u2013266 (2024).","journal-title":"J. Vasc Dis."},{"key":"36643_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/hrt.2004.049643","volume":"92","author":"D Roy","year":"2006","unstructured":"Roy, D. et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 92, 113\u2013114 (2006).","journal-title":"Heart"},{"key":"36643_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ajem.2017.03.018","volume":"35","author":"M Bolatkale","year":"2017","unstructured":"Bolatkale, M. et al. A novel biochemical marker for community-acquired pneumonia: Ischemia-modified albumin. Am. J. Emerg. Med. 35, 1121\u20131125 (2017).","journal-title":"Am. J. Emerg. Med."},{"key":"36643_CR19","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3855\/jidc.17456","volume":"17","author":"M Tanr\u0131verdi","year":"2023","unstructured":"Tanr\u0131verdi, M. et al. Could ischemia-modified albumin levels predict the severity of disease in SARS-CoV-2 infection? J. Infect. Dev. Ctries. 17, 1055\u20131062 (2023).","journal-title":"J. Infect. Dev. Ctries."},{"key":"36643_CR20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4236\/abb.2012.327119","volume":"3","author":"NA Ismail","year":"2012","unstructured":"Ismail, N. A. et al. Glutathione peroxidase, superoxide dismutase and catalase activities in children with chronic hepatitis. Adv. Biosci. Biotechnol. 3, 972\u2013977 (2012).","journal-title":"Adv. Biosci. Biotechnol."},{"key":"36643_CR21","doi-asserted-by":"publisher","first-page":"1362102","DOI":"10.3389\/fimmu.2024.1362102","volume":"15","author":"J Chu","year":"2024","unstructured":"Chu, J. et al. Superoxide dismutase alterations in COVID-19: implications for disease severity and mortality prediction in the context of Omicron variant infection. Front. Immunol. 15, 1362102 (2024).","journal-title":"Front. Immunol."},{"key":"36643_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat, V. et al. Descamps Latscha, B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49, 1304\u20131313 (1996).","journal-title":"Kidney Int."},{"key":"36643_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cca.2012.01.038","volume":"413","author":"M Hanasand","year":"2012","unstructured":"Hanasand, M. et al. Improved detection of advanced oxidation protein products in plasma. Clin. Chim. Acta. 413, 901\u2013906 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"36643_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0736-4679(00)00255-9","volume":"19","author":"D Bar-Or","year":"2000","unstructured":"Bar-Or, D., Lau, E. & Winkler, J. V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - A preliminary report. J. Emerg. Med. 19, 311\u2013315 (2000).","journal-title":"J. Emerg. Med."},{"key":"36643_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson, M., Szatrowski, T. P., Peterson, J. & Gold, J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 47, 1245\u20131251 (1994).","journal-title":"J. Clin. Epidemiol."},{"key":"36643_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/emj.2009.089383","volume":"28","author":"KY Jeong","year":"2011","unstructured":"Jeong, K. Y. et al. Prognostic value of N-terminal pro-brain natriuretic peptide in hospitalised patients with community-acquired pneumonia. Emerg. Med. J. 28, 122\u2013127 (2011).","journal-title":"Emerg. Med. J."},{"key":"36643_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1165\/rcmb.2011-0345OC","volume":"48","author":"S Yatmaz","year":"2013","unstructured":"Yatmaz, S. et al. Glutathione Peroxidase-1 reduces influenza A Virus\u2013Induced lung inflammation. Am. J. Respir Cell. Mol. Biol. 48, 17\u201326 (2013).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"36643_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/antiox12030548","volume":"12","author":"FS Bezerra","year":"2023","unstructured":"Bezerra, F. S. et al. Oxidative stress and inflammation in acute and chronic lung injuries. Antioxidants 12, 548 (2023).","journal-title":"Antioxidants"},{"key":"36643_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3889\/oamjms.2016.040","volume":"4","author":"L Muravlyova","year":"2016","unstructured":"Muravlyova, L. et al. Characteristic of the oxidative stress in blood of patients in dependence of Community-Acquired pneumonia severity. Maced J. Med. Sci. 4, 122\u2013127 (2016).","journal-title":"Maced J. Med. Sci."},{"key":"36643_CR30","first-page":"OA3247","volume":"46","author":"V Molotov-Luchanskiy","year":"2015","unstructured":"Molotov-Luchanskiy, V. et al. Biomarkers for oxidative stress in patients with community-acquired pneumonia. Eur. Respir J. 46, OA3247 (2015).","journal-title":"Eur. Respir J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36643-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:13:45Z","timestamp":1772194425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36643-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36643"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36643-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Nicolaus Copernicus University in Toru\u0144, Collegium Medicum in Bydgoszcz, Poland (KB 343\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"7809"}}